{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:45:11Z","timestamp":1792511111688,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07198-4","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T08:04:04Z","timestamp":1784880244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Addition of thiotepa to total body irradiation-based conditioning in allogeneic hematopoietic stem cell transplantation for relapsed\/refractory acute leukemia and lymphoma: a propensity score-matched retrospective study"],"prefix":"10.1007","volume":"105","author":[{"given":"Minglu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"19","key":"7198_CR1","doi-asserted-by":"publisher","first-page":"11259","DOI":"10.3390\/ijms231911259","volume":"23","author":"M Hennawi","year":"2022","unstructured":"Hennawi M, Pakasticali N, Tashkandi H, Hussaini M (2022) Genomic landscape of mixed-phenotype acute leukemia. Int J Mol Sci 23(19):11259. https:\/\/doi.org\/10.3390\/ijms231911259","journal-title":"Int J Mol Sci"},{"key":"7198_CR2","doi-asserted-by":"publisher","unstructured":"Paviglianiti A, Ngoya M, de la Peffault R, Schroeder T, Remenyi P, Morsink L et al (2026) Outcomes of mixed phenotype acute leukemia undergoing allogeneic stem cell transplantation: a retrospective study of the ALWP of EBMT. BMT. https:\/\/doi.org\/10.1038\/s41409-026-02920-2","DOI":"10.1038\/s41409-026-02920-2"},{"issue":"10","key":"7198_CR3","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1007\/s00277-025-06693-4","volume":"104","author":"F Huang","year":"2025","unstructured":"Huang F, Yang K, Du J, Xuan L, Liu Q (2025) Current scenario of allogeneic hematopoietic stem cell transplantation in adult patients with relapsed\/refractory acute myeloid leukemia: a narrative review. Ann Hematol 104(10):4913\u20134930. https:\/\/doi.org\/10.1007\/s00277-025-06693-4","journal-title":"Ann Hematol"},{"issue":"3","key":"7198_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jtct.2020.12.020","volume":"27","author":"I Aldoss","year":"2021","unstructured":"Aldoss I, Yang D, Malki MMA, Mei M, Mokhtari S, Artz A et al (2021) Allogeneic hematopoietic cell transplantation for relapsed and refractory philadelphia negative B cell ALL in the era of novel salvage therapies. Transpl Cell Ther 27(3):255.e1-255.e9 https:\/\/doi.org\/10.1016\/j.jtct.2020.12.020","journal-title":"Transpl Cell Ther"},{"issue":"24","key":"7198_CR5","doi-asserted-by":"publisher","first-page":"6117","DOI":"10.1182\/bloodadvances.2020002811","volume":"4","author":"NJ Short","year":"2020","unstructured":"Short NJ, Rafei H, Daver N, Hwang H, Ning J, Jorgensen JL et al (2020) Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML. Blood Adv 4(24):6117\u20136126. https:\/\/doi.org\/10.1182\/bloodadvances.2020002811","journal-title":"Blood Adv"},{"issue":"4","key":"7198_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1200\/JCO.20.02529","volume":"39","author":"C Peters","year":"2021","unstructured":"Peters C, Dalle JH, Locatelli F, Poetschger U, Sedlacek P, Buechner J et al (2021) Total body irradiation or chemotherapy conditioning in childhood ALL: A multinational, randomized, noninferiority phase III study. J Clin Oncol 39(4):295\u2013307. https:\/\/doi.org\/10.1200\/JCO.20.02529","journal-title":"J Clin Oncol"},{"issue":"7","key":"7198_CR7","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.jtct.2021.03.026","volume":"27","author":"F Khimani","year":"2021","unstructured":"Khimani F, Dutta M, Faramand R, Nishihori T, Perez AP, Dean E et al (2021) Impact of total body irradiation-based myeloablative conditioning regimens in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation: systematic review and meta-analysis. Transpl Cell Ther 27(7):620.e1-620.e9 https:\/\/doi.org\/10.1016\/j.jtct.2021.03.026","journal-title":"Transpl Cell Ther"},{"issue":"2","key":"7198_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jtct.2020.10.008","volume":"27","author":"B Dholaria","year":"2021","unstructured":"Dholaria B, Labopin M, Angelucci E, Tischer J, Arat M, Ciceri F et al (2021) Improved outcomes of haploidentical hematopoietic cell transplantation with total body irradiation-based myeloablative conditioning in acute lymphoblastic leukemia. Transpl Cell Ther 27(2):171.e1-171.e8 https:\/\/doi.org\/10.1016\/j.jtct.2020.10.008","journal-title":"Transpl Cell Ther"},{"key":"7198_CR9","doi-asserted-by":"publisher","first-page":"708906","DOI":"10.3389\/fonc.2021.708906","volume":"11","author":"J Vogel","year":"2021","unstructured":"Vogel J, Hui S, Hua CH, Dusenbery K, Rassiah P, Kalapurakal J et al (2021) Pulmonary toxicity after total body irradiation - critical review of the literature and recommendations for toxicity reporting. Front Oncol 11:708906. https:\/\/doi.org\/10.3389\/fonc.2021.708906","journal-title":"Front Oncol"},{"key":"7198_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.radonc.2022.05.027","volume":"173","author":"BAH Hoeben","year":"2022","unstructured":"Hoeben BAH, Pazos M, Seravalli E, Bosman ME, Losert C, Albert MH et al (2022) ESTRO ACROP and SIOPE recommendations for myeloablative Total Body Irradiation in children. Radiother Oncol 173:119\u2013133. https:\/\/doi.org\/10.1016\/j.radonc.2022.05.027","journal-title":"Radiother Oncol"},{"key":"7198_CR11","doi-asserted-by":"publisher","first-page":"100966","DOI":"10.1016\/j.blre.2022.100966","volume":"56","author":"R Handgretinger","year":"2022","unstructured":"Handgretinger R, Lang P (2022) Could (should) we abandon total body irradiation for conditioning in children with leukemia. Blood Rev 56:100966. https:\/\/doi.org\/10.1016\/j.blre.2022.100966","journal-title":"Blood Rev"},{"issue":"1","key":"7198_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00066-021-01810-4","volume":"198","author":"A Gruen","year":"2022","unstructured":"Gruen A, Exner S, Kuhl JS, von Stackelberg A, Budach V, Stromberger C et al (2022) Total body irradiation as part of conditioning regimens in childhood leukemia-long-term outcome, toxicity, and secondary malignancies. Strahlenther Onkol 198(1):33\u201338. https:\/\/doi.org\/10.1007\/s00066-021-01810-4","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"7198_CR13","doi-asserted-by":"publisher","first-page":"22e","DOI":"10.1016\/j.jtct.2024.10.007","volume":"31","author":"Y Naik","year":"2025","unstructured":"Naik Y, Kulkarni U, Lionel S, Selvarajan S, Devasia AJ, Korula A et al (2025) Total marrow and lymphoid irradiation (TMLI) is associated with good early outcomes in patients undergoing matched sibling donor and haplo-identical transplants for acute lymphoblastic leukemia. Transpl Cell Ther 31(1):22e. https:\/\/doi.org\/10.1016\/j.jtct.2024.10.007","journal-title":"Transpl Cell Ther"},{"issue":"1","key":"7198_CR14","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1186\/s12916-024-03830-0","volume":"22","author":"Z Hu","year":"2024","unstructured":"Hu Z, Feng Z, Liu S, He H, Dong Y, Fan Z et al (2024) Intensified conditioning containing decitabine versus standard myeloablative conditioning for adult patients with KMT2A-rearranged leukemia: a multicenter retrospective study. BMC Med 22(1):605. https:\/\/doi.org\/10.1186\/s12916-024-03830-0","journal-title":"BMC Med"},{"issue":"10","key":"7198_CR15","doi-asserted-by":"publisher","first-page":"e952","DOI":"10.1097\/HS9.0000000000000952","volume":"7","author":"F Saraceni","year":"2023","unstructured":"Saraceni F, Labopin M, Raiola AM, Blaise D, Remenyi P, Sora F et al (2023) Thiotepa-busulfan-fludarabine compared to treosulfan-based conditioning for haploidentical transplant with posttransplant cyclophosphamide in patients with acute myeloid leukemia in remission: a study from the acute leukemia working party of the EBMT. Hemasphere 7(10):e952. https:\/\/doi.org\/10.1097\/HS9.0000000000000952","journal-title":"Hemasphere"},{"issue":"1","key":"7198_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41409-022-01841-0","volume":"58","author":"A Banet","year":"2023","unstructured":"Banet A, Bazarbachi A, Labopin M, Stocker N, Dulery R, Malard F et al (2023) Thiotepa, busulfan and fludarabine conditioning-regimen is a promising approach for older adult patients with acute lymphoblastic leukemia treated with allogeneic stem cell transplantation. Bone Marrow Transpl 58(1):61\u201367. https:\/\/doi.org\/10.1038\/s41409-022-01841-0","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"7198_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41409-022-01865-6","volume":"58","author":"C Luo","year":"2023","unstructured":"Luo C, Wu G, Huang X, Ding Y, Huang Y, Song Q et al (2023) Myeloablative conditioning regimens in adult patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation in complete remission: a systematic review and network meta-analysis. Bone Marrow Transpl 58(2):175\u2013185. https:\/\/doi.org\/10.1038\/s41409-022-01865-6","journal-title":"Bone Marrow Transpl"},{"issue":"8","key":"7198_CR18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jtct.2023.04.022","volume":"29","author":"YI Cohen","year":"2023","unstructured":"Cohen YI, Lebel E, Zimran E, Shaulov A, Stepensky P, Grisariu S et al (2023) Long-term results with thiotepa-containing conditioning regimens for autologous stem cell transplantation. Transpl Cell Ther 29(8):505.e1-505.e8 https:\/\/doi.org\/10.1016\/j.jtct.2023.04.022","journal-title":"Transpl Cell Ther"},{"issue":"7","key":"7198_CR19","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1007\/s00277-025-06405-y","volume":"104","author":"DH Kim","year":"2025","unstructured":"Kim DH, Park T, Hong J, Shin DY, Kim I, Yoon SS et al (2025) Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide conditioning in patients with central nervous system lymphoma: a phase II study. Ann Hematol 104(7):3843\u20133854. https:\/\/doi.org\/10.1007\/s00277-025-06405-y","journal-title":"Ann Hematol"},{"issue":"10","key":"7198_CR20","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1080\/10428194.2022.2068005","volume":"63","author":"R Puckrin","year":"2022","unstructured":"Puckrin R, Chua N, Shafey M, Stewart DA (2022) Improving the outcomes of secondary CNS lymphoma with high-dose thiotepa, busulfan, melphalan, rituximab conditioning and autotransplant. Leuk Lymphoma 63(10):2444\u20132452. https:\/\/doi.org\/10.1080\/10428194.2022.2068005","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"7198_CR21","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1001\/jamaoncol.2021.1074","volume":"7","author":"M Scordo","year":"2021","unstructured":"Scordo M, Wang TP, Ahn KW, Chen Y, Ahmed S, Awan FT et al (2021) Outcomes associated with thiotepa-based conditioning in patients with primary central nervous system lymphoma after autologous hematopoietic cell transplant. JAMA Oncol 7(7):993\u20131003. https:\/\/doi.org\/10.1001\/jamaoncol.2021.1074","journal-title":"JAMA Oncol"},{"issue":"11","key":"7198_CR22","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1016\/j.bbmt.2020.07.028","volume":"26","author":"V Chinnabhandar","year":"2020","unstructured":"Chinnabhandar V, Tran S, Sutton R, Shaw PJ, Mechinaud F, Cole C et al (2020) Addition of thiotepa to total body irradiation and cyclophosphamide conditioning for allogeneic hematopoietic stem cell transplantation in pediatric acute lymphoblastic leukemia. Biol Blood Marrow Transpl 26(11):2068\u20132074. https:\/\/doi.org\/10.1016\/j.bbmt.2020.07.028","journal-title":"Biol Blood Marrow Transpl"},{"issue":"8","key":"7198_CR23","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41409-020-0854-0","volume":"55","author":"AM Willasch","year":"2020","unstructured":"Willasch AM, Peters C, Sedlacek P, Dalle JH, Kitra-Roussou V, Yesilipek A et al (2020) Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study. Bone Marrow Transpl 55(8):1540\u20131551. https:\/\/doi.org\/10.1038\/s41409-020-0854-0","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"7198_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1200\/JCO.22.00767","volume":"41","author":"H Zhang","year":"2023","unstructured":"Zhang H, Fan Z, Huang F, Han L, Xu Y, Xu N et al (2023) Busulfan plus cyclophosphamide versus total body irradiation plus cyclophosphamide for adults acute B lymphoblastic leukemia: an open-label, multicenter, phase III trial. J Clin Oncol 41(2):343\u2013353. https:\/\/doi.org\/10.1200\/JCO.22.00767","journal-title":"J Clin Oncol"},{"issue":"1","key":"7198_CR25","doi-asserted-by":"publisher","first-page":"e812","DOI":"10.1097\/HS9.0000000000000812","volume":"7","author":"A Spyridonidis","year":"2023","unstructured":"Spyridonidis A, Labopin M, Savani B, Giebel S, Bug G, Schonland S et al (2023) Reduced 8-gray compared to standard 12-gray total body irradiation for allogeneic transplantation in first remission acute lymphoblastic leukemia: A study of the acute leukemia working party of the EBMT. Hemasphere 7(1):e812. https:\/\/doi.org\/10.1097\/HS9.0000000000000812","journal-title":"Hemasphere"},{"issue":"6","key":"7198_CR26","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41409-022-01626-5","volume":"57","author":"F Bonifazi","year":"2022","unstructured":"Bonifazi F, Pavoni C, Peccatori J, Giglio F, Arpinati M, Busca A et al (2022) Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01. Bone Marrow Transpl 57(6):949\u2013958. https:\/\/doi.org\/10.1038\/s41409-022-01626-5","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"7198_CR27","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41409-021-01550-0","volume":"57","author":"R Swoboda","year":"2022","unstructured":"Swoboda R, Labopin M, Giebel S, Angelucci E, Arat M, Aljurf M et al (2022) Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia Working Party of the EBMT. Bone Marrow Transpl 57(3):399\u2013406. https:\/\/doi.org\/10.1038\/s41409-021-01550-0","journal-title":"Bone Marrow Transpl"},{"issue":"6","key":"7198_CR28","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s11912-023-01403-7","volume":"25","author":"T Hilal","year":"2023","unstructured":"Hilal T, Mountjoy LJ (2023) Allogeneic hematopoietic stem cell transplant for diffuse large B-cell lymphoma: evolving role in the era of CAR T-cell therapy. Curr Oncol Rep 25(6):599\u2013607. https:\/\/doi.org\/10.1007\/s11912-023-01403-7","journal-title":"Curr Oncol Rep"},{"issue":"9","key":"7198_CR29","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.jcyt.2022.03.004","volume":"24","author":"K Harada","year":"2022","unstructured":"Harada K, Morita-Fujita M, Fukuda T, Ozawa Y, Doki N, Toyosaki M et al (2022) Overcoming minimal residual disease using intensified conditioning with medium-dose etoposide, cyclophosphamide and total body irradiation in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults. Cytotherapy 24(9):954\u2013961. https:\/\/doi.org\/10.1016\/j.jcyt.2022.03.004","journal-title":"Cytotherapy"},{"issue":"11","key":"7198_CR30","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1182\/blood.2021014804","volume":"139","author":"G Paras","year":"2022","unstructured":"Paras G, Morsink LM, Othus M, Milano F, Sandmaier BM, Zarling LC et al (2022) Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML. Blood 139(11):1694\u20131706. https:\/\/doi.org\/10.1182\/blood.2021014804","journal-title":"Blood"},{"issue":"2","key":"7198_CR31","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3368\/jhr.50.2.373","volume":"50","author":"GW Imbens","year":"2015","unstructured":"Imbens GW (2015) Matching methods in practice: three examples. J Hum Resour 50(2):373\u2013419. https:\/\/doi.org\/10.3368\/jhr.50.2.373","journal-title":"J Hum Resour"},{"issue":"1","key":"7198_CR32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1182\/blood-2009-12-257253","volume":"116","author":"J Choi","year":"2010","unstructured":"Choi J, Ritchey J, Prior JL, Holt M, Shannon WD, Deych E et al (2010) In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia. Blood 116(1):129\u2013139. https:\/\/doi.org\/10.1182\/blood-2009-12-257253","journal-title":"Blood"},{"issue":"12","key":"7198_CR33","doi-asserted-by":"publisher","first-page":"125008","DOI":"10.1117\/1.jbo.20.12.125008","volume":"20","author":"M Curra","year":"2015","unstructured":"Curra M, Pellicioli ACA, Filho NAK, Ochs G, Matte UDS, Sant\u2019Ana Filho M et al (2015) Photobiomodulation reduces oral mucositis by modulating NF-kB. J Biomed Opt 20(12):125008. https:\/\/doi.org\/10.1117\/1.jbo.20.12.125008","journal-title":"J Biomed Opt"},{"issue":"7","key":"7198_CR34","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/aje\/kwq198","volume":"172","author":"T Sturmer","year":"2010","unstructured":"Sturmer T, Rothman KJ, Avorn J, Glynn RJ (2010) Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution\u2013A simulation study. Am J Epidemiol 172(7):843\u2013854. https:\/\/doi.org\/10.1093\/aje\/kwq198","journal-title":"Am J Epidemiol"},{"key":"7198_CR35","doi-asserted-by":"publisher","unstructured":"Chatton A, Rohrer JM (2024) The causal cookbook: recipes for propensity scores, G-computation, and doubly robust standardization. Adv Methods Pract Psychol Sci 7(1). https:\/\/doi.org\/10.1177\/25152459241236149","DOI":"10.1177\/25152459241236149"},{"issue":"3","key":"7198_CR36","doi-asserted-by":"publisher","first-page":"e1003348","DOI":"10.1371\/journal.pgen.1003348","volume":"9","author":"F Dudbridge","year":"2013","unstructured":"Dudbridge F (2013) Power and predictive accuracy of polygenic risk scores. PLoS Genet 9(3):e1003348. https:\/\/doi.org\/10.1371\/journal.pgen.1003348","journal-title":"PLoS Genet"},{"issue":"1","key":"7198_CR37","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1748-717x-8-92","volume":"8","author":"A Gruen","year":"2013","unstructured":"Gruen A, Ebell W, Wlodarczyk W, Neumann O, Kuehl JS, Stromberger C et al (2013) Total body irradiation (TBI) using helical tomotherapy in children and young adults undergoing stem cell transplantation. Radiat Oncol 8(1):92. https:\/\/doi.org\/10.1186\/1748-717x-8-92","journal-title":"Radiat Oncol"},{"issue":"25","key":"7198_CR38","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin PC (2009) Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 28(25):3083\u20133107. https:\/\/doi.org\/10.1002\/sim.3697","journal-title":"Stat Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07198-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07198-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07198-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:01:59Z","timestamp":1792508519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07198-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":38,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["7198"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07198-4","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"28 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of the Aerospace central Hospital.","order":1,"name":"Ethics","label":"Permission to reproduce material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Patient consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have fully disclosed their conflicts of interest in the manuscript and during the submission process. This manuscript has not been published and is not under consideration for publication elsewhere.","order":4,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"467"}}